Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic intestinal pseudo-obstruction].

Francisca Joly1, Aurélien Amiot, Benoît Coffin

  • 1Service de Gastroentérologie et d'Assistance nutritive, Hôpital Beaujon, 100 Boulevard du Général Leclerc, Clichy-la-Garenne, 92110 Clichy cedex.

Gastroenterologie Clinique Et Biologique
|November 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID.

Clinics and research in hepatology and gastroenterology·2026
Same author

Comparative risk of serious infection in patients with ulcerative colitis treated with JAK inhibitors.

Journal of Crohn's & colitis·2026
Same author

Serious Infection in Inflammatory Bowel Diseases Patients Treated With Vedolizumab, Ustekinumab, Janus Kinase Inhibitors, Anti-Tumor Necrosis Factor or Aminosalicylates.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.

Alimentary pharmacology & therapeutics·2026
Same author

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

United European gastroenterology journal·2026
Same author

Histogenetic Classification Predicts Outcomes in 130 Adults With Chronic Intestinal Pseudo-Obstruction.

The American journal of gastroenterology·2026
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
See all related articles

Chronic intestinal pseudo-obstruction (CIPO) presents with symptoms mimicking bowel blockage without a physical cause. Management focuses on symptom relief and nutritional support to prevent malnutrition.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pathophysiology

Context:

  • Chronic intestinal pseudo-obstruction (CIPO) is a rare gastrointestinal motility disorder.
  • It presents with symptoms mimicking mechanical bowel obstruction but lacks an organic cause.
  • CIPO can stem from primary or secondary factors, impacting patient quality of life.

Purpose:

  • To outline the diagnostic principles for CIPO, emphasizing the exclusion of mechanical obstruction.
  • To detail the management strategies focused on symptomatic control and nutritional support.
  • To review treatment options including prokinetic agents, antibiotics, nutritional therapies, and intestinal transplantation.

Summary:

  • CIPO diagnosis requires excluding mechanical obstruction and assessing gastrointestinal physiology and extra-intestinal manifestations.

Related Experiment Videos

  • Management prioritizes symptom control and nutritional support to prevent malnutrition and electrolyte imbalances.
  • Treatment involves prokinetic agents, antibiotics for bacterial overgrowth, enteral nutrition, and potentially parenteral nutrition or intestinal transplantation.

    • Impact:

    • Improved diagnostic accuracy for CIPO.
    • Enhanced patient outcomes through effective symptom management and nutritional support.
    • Guidance for clinicians on comprehensive CIPO care, including advanced interventions.